Israel Englander Teva Pharmaceutical Industries LTD Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $103,518 - $140,940	-8,100 Reduced 16.27%	41,700 $677,000
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $2.21 Million - $2.99 Million	-207,000 Reduced 80.61%	49,800 $702,000
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $1.01 Million - $1.33 Million	-125,000 Reduced 32.74%	256,800 $2.68 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $7,200 - $9,470	1,000 Added 0.26%	381,800 $2.87 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $3.97 Million - $5.4 Million	-475,300 Reduced 55.52%	380,800 $3.37 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $19 Million - $22.7 Million	-2,394,200 Reduced 73.66%	856,100 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $214,032 - $372,840	31,200 Added 0.97%	3,250,300 $26.2 Million

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.